United Drug acquires pharma contractors for $33M; Numoda will handle PhI for Proteonomix's liver drug;

> United Drug has bought pharma risk-management contractor Drug Safety Alliance for $21 million and market-access firm Synopia for $12 million. News

> Numoda has signed up to conduct Phase I trials for Proteonomix's UMK-121 for end-stage liver disease. More

> Harlan Laboratories is expanding its agrochemicals and global pathology units, appointing new general managers for each. Story

> Icon ($ICLR) is expanding some of its labs in the U.S. and U.K., adding space for dedicated immunoassay development. Article

> WuXi PharmaTech ($WX) has entered a drug discovery pact with Open Monoclonal Technology, looking to discover antibodies using OMT's rat models. Report

> CMIC got qualification for three new development suites in New Jersey, a development the company says will help speed up drug development. Item



Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.

PRA Health has hired a former FDA clinical research lead to help run its decentralized study unit.